Aditxt (ADTX) Interest Coverage Ratio (2022 - 2026)
Aditxt (ADTX) recorded quarterly Interest Coverage Ratio of 160.74 in Q1 2026, down 931.92% quarter-over-quarter from 15.58 in Q4 2025, and down 351.43% on a YoY basis from 63.93 in Q1 2025.
Aditxt (ADTX) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Aditxt's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 160.74 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 351.43% year-over-year to 160.74; the TTM figure through Mar 2026 stood at 33.27 (down 181.67% YoY), while the FY2025 annual figure was 28.73, down 331.92% from the prior year.
- Interest Coverage Ratio was 160.74 for Q1 2026 at Aditxt, down from 15.58 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.3 in Q2 2023 to a low of 643.8 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 81.62 across 5 years, with a median of 15.58 in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio soared 99.32% in 2023, then plunged 3277.14% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 643.8 in 2022, then soared by 99.32% to 4.4 in 2023, then slumped by 3277.14% to 148.72 in 2024, then jumped by 89.53% to 15.58 in 2025, then slumped by 931.92% to 160.74 in 2026.
- The last three Interest Coverage Ratio figures came in at 160.74 (Q1 2026), 15.58 (Q4 2025), and 17.79 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -160.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160.74 |
| Dec 31, 2025 | -15.58 |
| Sep 30, 2025 | -17.79 |
| Jun 30, 2025 | -129.93 |
| Mar 31, 2025 | -35.61 |
| Dec 31, 2024 | -148.72 |
| Sep 30, 2024 | -8.25 |
| Jun 30, 2024 | -5.47 |
| Mar 31, 2024 | -4.63 |
| Dec 31, 2023 | -4.40 |
| Sep 30, 2023 | -8.93 |
| Jun 30, 2023 | -3.30 |
| Mar 31, 2023 | -29.13 |
| Dec 31, 2022 | -643.80 |
| Sep 30, 2022 | -8.05 |